docosahexaenoic acid and its lipid mediators prevent neuroinflammation by inhibiting transcription factor nfkappab, preventing cytokine secretion, blocking the synthesis of prostaglandins, leukotrienes, and thromboxanes, and modulating leukocyte trafficking.